☆ 4.7 Review

Effectiveness of adjunctive rifampicin for treatment of Staphylococcus aureus bacteraemia: a systematic review and meta-analysis of randomized controlled trials

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Methods for deriving risk difference (absolute risk reduction) from a meta-analysis

M. Hassan Murad et al.

Summary: Trading off benefits and harms requires knowledge of the absolute risk reduction or risk difference, making risk difference a critical measure for decision making. However, estimating risk difference is not straightforward and the available methods have various limitations. This article discusses four methods for estimating risk difference and provides recommendations on when to use each approach.

BMJ-BRITISH MEDICAL JOURNAL (2023)

Add to Collection

Review Infectious Diseases

Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis

Anthony D. Bai et al.

Summary: The mortality rate of Staphylococcus aureus bacteremia has decreased over the past three decades, but one in four patients still die within three months. Methicillin-resistant Staphylococcus aureus infection is associated with a higher mortality rate, while more recent time periods have shown lower mortality rates.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Review Microbiology

The Effectiveness of Combination Therapy for Treating Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Literature Review and a Meta-Analysis

Sara Grillo et al.

Summary: This meta-analysis found that combination therapy did not significantly decrease mortality in patients with MSSA bacteremia, but increased the risk of adverse events. However, adjunctive rifampicin may reduce 90-day mortality in patients with deep-seated infections. Combination therapy was associated with a decreased risk of relapse, but this benefit was not maintained in the pooled randomized controlled trials.

MICROORGANISMS (2022)

Add to Collection

Article Immunology

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

Steven Y. C. Tong et al.

Summary: The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is a multicenter international adaptive platform trial that aims to address multiple key questions in the management of S. aureus bloodstream infections. It involves over 7000 adult and child participants and commenced enrolling patients in multiple countries in 2022.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis

Jonathan H. Ryder et al.

Summary: This article synthesizes clinical data and concludes that adjunctive use of gentamicin or rifampin does not provide clinical benefit in staphylococcal prosthetic valve endocarditis. Rifampin is associated with longer hospitalizations and frequent adverse events requiring treatment discontinuation.

OPEN FORUM INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

Miquel Pujol et al.

Summary: The study found that daptomycin plus fosfomycin provided a slightly higher treatment success rate for MRSA bacteremia and endocarditis compared to daptomycin alone, but this difference was not statistically significant. The antibiotic combination was associated with lower rates of microbiological failure and complicated bacteremia, but was also more frequently linked to adverse events.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial

Matthew P. Cheng et al.

Summary: The study aimed to determine the efficacy of synergistic treatment with daptomycin when given with either cefazolin or cloxacillin for the treatment of MSSA BSI. Results showed that adjunctive daptomycin therapy did not shorten the duration of bacteremia when added to standard-of-care treatment for MSSA BSIs, and should not be routinely considered.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial

A. J. Campbell et al.

Summary: This pilot RCT aimed to determine the feasibility of conducting a clinical trial to examine if adjunctive clindamycin with standard therapy has greater efficacy than standard therapy alone for S. aureus infections.

JAC-ANTIMICROBIAL RESISTANCE (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial

Steven Y. C. Tong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis

Huan Ma et al.

PLOS ONE (2020)

Add to Collection

Article Medicine, General & Internal

Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials

Adrien Lemaignen et al.

BMJ OPEN (2020)

Add to Collection

Article Infectious Diseases

Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial

Alexander Szubert et al.

JOURNAL OF INFECTION (2019)

Add to Collection

Article Medicine, General & Internal

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy E. Thwaites et al.

LANCET (2018)

Add to Collection

Article Health Care Sciences & Services

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT

Guy E. Thwaitest et al.

HEALTH TECHNOLOGY ASSESSMENT (2018)

Add to Collection

Article Immunology

Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study

Anthony D. Bai et al.

CLINICAL INFECTIOUS DISEASES (2015)

Add to Collection

Review Microbiology

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Steven Y. C. Tong et al.

CLINICAL MICROBIOLOGY REVIEWS (2015)

Add to Collection

Review Microbiology

Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review

Clark D. Russell et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2014)

Add to Collection

Article Medicine, Research & Experimental

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial

Guy Thwaites et al.

TRIALS (2012)

Add to Collection

Review Infectious Diseases

Clinical management of Staphylococcus aureus bacteraemia

Guy E. Thwaites et al.

LANCET INFECTIOUS DISEASES (2011)

Add to Collection

Review Microbiology

Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Guy E. Thwaites et al.

NATURE REVIEWS MICROBIOLOGY (2011)

Add to Collection

Review Microbiology

Rifampin Combination Therapy for Nonmycobacterial Infections

Graeme N. Forrest et al.

CLINICAL MICROBIOLOGY REVIEWS (2010)

Add to Collection

Article Critical Care Medicine

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia

Young Ju Jung et al.

CRITICAL CARE MEDICINE (2010)

Add to Collection

Review Medicine, General & Internal

Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections

Joshua Perlroth et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

Add to Collection

Article Medicine, General & Internal

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

Vance G. Fowler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Add to Collection

Article Microbiology

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia

J. John Weems et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Add to Collection

Article Infectious Diseases

The role of aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis:: a meta-analysis of comparative trials

ME Falagas et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Add to Collection

Article Medicine, General & Internal

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment:: a prospective and randomized clinical trial of 381 patients

E Ruotsalainen et al.

JOURNAL OF INTERNAL MEDICINE (2006)

Add to Collection

Article Immunology

A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection

J Schrenzel et al.

CLINICAL INFECTIOUS DISEASES (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.